<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2016-07-27 08:19:27Neurochemistry Medicine Clinical medicine Complement deficiency RTT Sodium channel blockers Euphoriants Calcium channel blockers Hereditary angioedema Syringe Angioedema Ketamine |
Add to Reading List |
Microsoft Word - CINRYZE.Product Monographdoc | Beilage 1: ArzneimittelmonographienDocID: 1rinj - View Document |
| Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion Idursulfase â–¼This medicine is subject to additional monitoring. This will allow quick identification of new safety informDocID: 1reFq - View Document |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ORENITRAM® safely and effectively. See Full Prescribing Information for ORENITRAM. --------------------- DOSAGE FODocID: 1rcHl - View Document |
| Strensiq, INN-asfotase alfaDocID: 1rcrc - View Document |
| Microsoft Word - CINRYZE.Product MonographdocDocID: 1qE2h - View Document |